Medvi scrutiny raises alarms over AI-enabled business practices

NEW YORK (AP). The two-employee startup Medvi, recently profiled by The New York Times for surpassing $1 billion in revenue, has become a focal point for concerns about AI-powered business opacity after investigative reporting questioned its operational claims. The company, which purportedly uses artificial intelligence to automate medical billing and patient acquisition for weight-loss drug providers, drew criticism from AI researcher Gary Marcus for potentially misleading metrics and inadequate transparency about its technology stack. The Times story highlighted Medvi's revenue growth without scrutinizing whether the figures represented gross transaction volume or net revenue, a distinction that would dramatically alter valuation assessments. The case illustrates growing regulatory and journalistic scrutiny of AI startups that achieve unicorn-scale metrics with minimal headcount, raising questions about due diligence standards as venture capital rushes to deploy capital in the sector. Critics argue the episode shows how AI branding can obscure traditional business due diligence.